These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12895134)

  • 1. Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.
    Pietra B; Boucek M
    Paediatr Drugs; 2003; 5(8):513-24. PubMed ID: 12895134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft vasculopathy.
    Lee MS; Finch W; Weisz G; Kirtane AJ
    Rev Cardiovasc Med; 2011; 12(3):143-52. PubMed ID: 22080925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy.
    Rhodes LR
    Crit Care Nurs Q; 2004; 27(1):10-6. PubMed ID: 14974521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft vasculopathy: A review.
    Lee MS; Tadwalkar RV; Fearon WF; Kirtane AJ; Patel AJ; Patel CB; Ali Z; Rao SV
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E527-E536. PubMed ID: 30265435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pediatric heart transplant coronary vasculopathy with abnormal hemodynamic measures.
    Aiyagari R; Nika M; Gurney JG; Donohue JE; Zamberlan MC; King K; Crowley DC; Gajarski RJ
    Congenit Heart Dis; 2011; 6(2):128-33. PubMed ID: 21426526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells and transplant vasculopathy.
    Boilson BA; McGregor CG
    Minerva Cardioangiol; 2009 Apr; 57(2):233-47. PubMed ID: 19274032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapies for cardiac allograft vasculopathy in children.
    Kindel SJ; Pahl E
    Congenit Heart Dis; 2012; 7(4):324-35. PubMed ID: 22613206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients.
    Kindel SJ; Law YM; Chin C; Burch M; Kirklin JK; Naftel DC; Pruitt E; Carboni MP; Arens A; Atz AM; Dreyer WJ; Mahle WT; Pahl E
    J Am Coll Cardiol; 2015 Aug; 66(5):547-57. PubMed ID: 26227194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation.
    Spitaleri G; Farrero Torres M; Sabatino M; Potena L
    Expert Opin Pharmacother; 2020 Aug; 21(11):1367-1376. PubMed ID: 32401066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical dilemma of cardiac allograft vasculopathy--an introduction to the clinical session.
    von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/40-4. PubMed ID: 11151791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in cardiac allograft vasculopathy: potential pharmacological interventions.
    Osto E; Tona F; De Bon E; Iliceto S; Cella G
    Curr Vasc Pharmacol; 2010 Mar; 8(2):169-88. PubMed ID: 19485920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of optical coherence tomography in pediatric heart transplant patients.
    Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R
    Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
    Delgado JF; Manito N; Segovia J; Almenar L; Arizón JM; Campreciós M; Crespo-Leiro MG; Díaz B; González-Vílchez F; Mirabet S; Palomo J; Roig E; de la Torre JM
    Transplant Rev (Orlando); 2009 Apr; 23(2):69-79. PubMed ID: 19298938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Kobayashi D; Du W; L'ecuyer TJ
    Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of coronary artery vasculopathy.
    Crespo-Leiro MG; Marzoa-Rivas R; Barge-Caballero E; Paniagua-Martín MJ
    Curr Opin Organ Transplant; 2012 Oct; 17(5):546-50. PubMed ID: 22941320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presentation and diagnosis of coronary allograft vasculopathy in pediatric heart transplant recipients.
    Jeewa A; Dreyer WJ; Kearney DL; Denfield SW
    Congenit Heart Dis; 2012; 7(4):302-11. PubMed ID: 22497818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Wellnhofer E; Hiemann NE; Ewert P; Lehmkuhl HB; Meyer R; Miera O; Peters B; Hetzer R; Berger F
    J Heart Lung Transplant; 2008 May; 27(5):514-21. PubMed ID: 18442717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.